LeukoDx and GE Healthcare Enter Agreement to Explore Solutions for Cell Characterization in Cell Therapy Manufacturing
16 mars 2016 10h00 HE
|
LeukoDx;GE Healthcare
JERUSALEM, ISRAEL--(Marketwired - March 16, 2016) -
LeukoDx, an emerging leader in the field of fully-automated cell-based assays, and GE Healthcare's Life Sciences business, a provider of...
LeukoDx Promoting Rapid Diagnosis and Treatment of Sepsis on World Sepsis Day 2015
13 sept. 2015 09h00 HE
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Sep 13, 2015) - LeukoDx, developers of a compact device for diagnosing life-threatening sepsis, is joining doctors, hospitals, healthcare systems,...
LeukoDx Chosen as a 2015 Red Herring Europe Winner
27 avr. 2015 09h00 HE
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Apr 27, 2015) - Red Herring announced its Red Herring Europe award winners, recognizing Europe's leading private companies and celebrating these...
LeukoDx Inc. Announces Appointment of Dr. Tobias Volker as Senior Vice President for Commercial Operations
21 avr. 2015 09h00 HE
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Apr 21, 2015) - LeukoDx Inc., an emerging leader in the field of innovative medical diagnostic technology, announced today the appointment of Dr....
LeukoDx Inc. Chosen as a 2015 Red Herring Top 100 Europe Finalist
24 mars 2015 09h00 HE
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Mar 24, 2015) - LeukoDx Inc., the creator of the Accellix automated flow cytometry platform, announced today that it has been selected as a Finalist...
LeukoDx Inc. Receives European CE Mark Approval and ISO Certification for Accellix(TM)
27 janv. 2015 09h00 HE
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Jan 27, 2015) - LeukoDx Inc., an emerging leader in the field of innovative medical diagnostic technology, today announced that it has completed all...
LeukoDx Inc. Announces Appointment of Dr. Ephraim Carlebach as Senior Vice President R&D
30 sept. 2014 08h00 HE
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Sep 30, 2014) - LeukoDx Inc., the creator of the Accellix automated flow cytometry platform, today announced the appointment of Ephraim Carlebach,...
LeukoDx Inc. Closes $7M Financing Round; Appoints Seymour Liebman & Mark Chess to BOD
16 juin 2014 09h00 HE
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Jun 16, 2014) - LeukoDx Inc., the creator of the Accellix automated flow cytometry platform, today announced that it has secured $7 million in new...
LeukoDx Inc. Reaches Key Prototype Milestone, Closes on the Second Tranche of $2 Million as Part of Its $8 Million in Funding Commitment
08 nov. 2012 11h38 HE
|
LeukoDx
TOWSON, MD and JERUSALEM--(Marketwire - Nov 8, 2012) - LeukoDx Inc. is pleased to announce it has reached a significant milestone by completing the development of a functional alpha prototype of...
LeukoDx Receives Third Year Chief Scientist Grant for 50% of $1.15 Million R&D Budget
15 mai 2012 10h00 HE
|
LeukoDx
JERUSALEM--(Marketwire - May 15, 2012) - LeukoDx Ltd. is pleased to announce that it has secured approval for a grant from the Office of the Chief Scientist in Israel for the third year. The...